Disease Markers

Biomarkers in Emergency Medicine


Status
Published

1Sapienza University of Rome, Rome, Italy

2Konkuk University, Seoul, Republic of Korea

3Facoltà di Medicina e Psicologia, Roma, Italy


Biomarkers in Emergency Medicine

Description

The biomarkers are compounds that can be measured and evaluated as indicators of normal biological processes and pathogenic processes or in pharmacologic responses to a drug. A “biomarker” is any laboratory tool with the potential to detect and characterize diseases more easily, to simplify complex clinical algorithms, and to improve clinical problem solving in emergency and in routine care. An ideal biomarker should aid in early diagnosis, help in risk stratification, be able to monitor the response to treatment, and predict outcomes. In emergency medicine, the most interesting are the circulating biomarkers which are easily accessible markers measured in blood, saliva, or urine and give huge information about diseases. In this field, the use of biomarkers has changed approach of diagnosis and treatment procedures assuming a greater significance in clinical decision-making where they help in diagnostic as well as in prognosis and to the subsequent faster patient disposition.

The journal will publish peer-reviewed high-quality articles, both original research articles and review articles.

Potential topics include but are not limited to the following:

  • Novel biomarkers in emergency medicine
  • New application of existing biomarkers
  • Multibiomarkers approach in acute diseases
  • Biomarkers in acute coronary syndrome (ACS)
  • Biomarkers in acute heart failure (AHF)
  • Biomarkers in sepsis
  • Biomarkers in acute kidney injury (AKI)

Articles

  • Special Issue
  • - Volume 2018
  • - Article ID 4597489
  • - Editorial

Biomarkers in Emergency Medicine

Patrizia Cardelli | Mina Hur | Salvatore Di Somma
  • Special Issue
  • - Volume 2018
  • - Article ID 6597387
  • - Research Article

Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome

Beata Morawiec | Damian Kawecki | ... | Ewa Nowalany-Kozielska
  • Special Issue
  • - Volume 2017
  • - Article ID 1204295
  • - Research Article

Is MicroRNA-127 a Novel Biomarker for Acute Pancreatitis with Lung Injury?

Na Shi | Lihui Deng | ... | Qing Xia
  • Special Issue
  • - Volume 2017
  • - Article ID 9126560
  • - Research Article

Increased Levels of S100A8/A9 in Patients with Peritonsillar Abscess: A New Promising Diagnostic Marker to Differentiate between Peritonsillar Abscess and Peritonsillitis

Christoph Spiekermann | Antonella Russo | ... | Thomas Vogl
  • Special Issue
  • - Volume 2017
  • - Article ID 5434310
  • - Research Article

Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis

Piergiorgio Lochner | Roberto Cantello | ... | Cristoforo Comi
  • Special Issue
  • - Volume 2017
  • - Article ID 3649693
  • - Research Article

Overexpression of miR-24 Is Involved in the Formation of Hypocoagulation State after Severe Trauma by Inhibiting the Synthesis of Coagulation Factor X

Lu-Jia Chen | Lian Yang | ... | Li-Bo Chen
Disease Markers
 Journal metrics
Acceptance rate34%
Submission to final decision88 days
Acceptance to publication43 days
CiteScore3.500
Impact Factor2.738
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.